L7 Informatics is a groundbreaking startup offering a Unified Platform with Workflow Orchestration and Data Contextualization, grounded in FAIR principles. The company, founded in 2011 and headquartered in the United States, provides a unified data and process platform (L7|ESP™) to streamline and optimize manufacturing, laboratory, and business processes across life sciences and healthcare value chains. L7 Informatics’ last investment of $38.00M came from Banneker Partners in a Series C investment on 07 June 2022. The company’s Unified Platform L7|ESP, with its Workflow Orchestration and Data Contextualization, is designed to meet the organizational needs of any life science organization digitalizing their data and laboratory processes, resulting in maximized total ROI, increased utilization and efficiency, and decreased overall cost. L7|ESP captures routine information in smaller labs, while also driving sophisticated wet and dry laboratory processes across enterprise organizations. The platform integrates all common data information management systems, including LIMS, Notebooks, and MES, as well as other resources such as instrument connectors, sample registration, logistics, scheduling, inventory, and data analytics. L7|ESP is built by scientists for the life sciences community—relentlessly focusing on serving customers in research, pharma, and diagnostics with the goal of better patient outcomes. The company is supporting customers around the globe that are tackling some of the most challenging and exciting opportunities in healthcare.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Series C | $38.00M | 1 | 07 Jun 2022 | |
Series B | $13.00M | 1 | 08 Mar 2021 | |
Series A | $4.59M | - | 02 Dec 2019 | |
Series A | $4.00M | - | 06 Dec 2017 | |
Series A | $1.50M | - | 27 Oct 2016 |
No recent news or press coverage available for L7 Informatics.